Analysis of the Efficacy of Immunotherapy on the Posterior Lines 
of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer

Analysis of the Efficacy of Immunotherapy on the Posterior Lines 
of Advanced EGFR Mutant Patients with Non-small cell Lung Cancer

Background and objective Immune checkpoint inhibitor monotherapy is reported to have little effect in advanced non-small cell lung cancer (NSCLC) patients with driver oncogenes. However, recent studies have shown that some patients with driver genes are still benefit from combination immunotherapy a...

Full description

Bibliographic Details
Main Authors: Li MA, Na QIN, Xinyong ZHANG, Yuhua WU, Haoyang LI, Mengjun YU, Zichen LIU, Jinghui WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
epidermal growth factor receptor
gene mutation
immunotherapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.104.06

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2021.104.06

Similar Items